Bloom Energy to Announce Fourth Quarter 2021 Financial Results and Outlook on February 10, 2022

Bloom Energy to Announce Fourth Quarter 2021 Financial Results and Outlook on February 10, 2022

SAN JOSE, Calif., January 25, 2022 — Bloom Energy (NYSE: BE) today announced it will release its fourth quarter and fiscal year 2021 financial results on February 10, 2022 after market close. Bloom Energy’s management will host a conference call at 2:00 p.m. Pacific Time (PT) / 5:00 p.m. Eastern Time (ET) on the same day to discuss these results and the longer term outlook for the company. ...  Read more

Anne Arundel Economic Development: VOLT Growth Fund

Anne Arundel Economic Development: VOLT Growth Fund

The VOLT Growth Fund (VGF) aims to help Maryland based high growth innovative and technology product companies implement a go-to-market strategy and accelerate sales.  The program has flexible underwriting standards and payment terms to allow a company to grow its revenue and workforce as well as facilitate future equity investment. ...  Read more

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine

NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains

GAITHERSBURG, Md., Feb. 1, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2. ...  Read more